Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06122090

Treatment of Hypopigmented Scars With Bimatoprost

Led by Medstar Health Research Institute · Updated on 2024-05-03

25

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

Sponsors

M

Medstar Health Research Institute

Lead Sponsor

L

Latham Fund

Collaborating Sponsor

AI-Summary

What this Trial Is About

Patients who have hypo-pigmented burn scar will have two scars chosen and randomized to treated scar and control scar. The subject will then have both scars treated with fractional ablative CO2 laser (FLSR). The treated scar will have bimatoprost delivered through the laser channels, while the control will have the vehicle (normal saline) only delivered. The treatment will continue for 14 days with twice daily application. The scars will then be monitored at a 2-week follow-up visit where levels of melanin will be evaluated. Tissue punch biopsies will also be used to evaluate the mechanism of action of bimatoprost. Treatment will occur for 6 sessions at 4-6 week intervals including follow- up visits and evaluations.

CONDITIONS

Official Title

Treatment of Hypopigmented Scars With Bimatoprost

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Cutaneous trauma resulting in hypopigmented scar
  • Two different hypopigmented scars, each at least 30cm2, separated by at least 2 inches of normal skin, hyperpigmented scar, or hypopigmented scar
Not Eligible

You will not qualify if you...

  • Target hypopigmented scar located on face or genitalia
  • Known allergy to bimatoprost
  • Known allergy to lidocaine
  • Positive urine pregnancy test in women of childbearing potential
  • Lactating women
  • Prisoner status

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

MedStar Washington Hospital Center

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

Loading map...

Research Team

A

Alison Ross, BA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here